Clinical Trials Logo

Pediatric Cancer clinical trials

View clinical trials related to Pediatric Cancer.

Filter by:

NCT ID: NCT06170385 Recruiting - Neoplasms Clinical Trials

Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia

PEACE
Start date: April 15, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility and acceptability of a hybrid in-person and virtual individualized physiotherapy program using the Healthy Eating and Active Living (HEAL-ME) online platform for children diagnosed with acute lymphoblastic leukemia. We would like to know if this type of hybrid program delivery model is feasible, and if children and their parents are willing and able to participate in the program. We will do this by recording how many, and what type of physiotherapy sessions (in-person or virtual) are completed, what resources offered on the platform are accessed, and how many children complete the assessments.

NCT ID: NCT06145321 Recruiting - Pediatric Cancer Clinical Trials

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Start date: November 23, 2023
Phase: Phase 4
Study type: Interventional

The investigators hypothesized that in terms of granulocyte colony-stimulating factor (G-CSF) administration, the route of continuous infusion would lead to a faster neutrophil recovery compared to that of bolus administration

NCT ID: NCT06120764 Recruiting - Pediatric Cancer Clinical Trials

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting

Start date: November 5, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric hematology-oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.

NCT ID: NCT06088030 Recruiting - Pediatric Cancer Clinical Trials

Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer

Start date: December 13, 2023
Phase: Phase 2
Study type: Interventional

This prospective, single-arm, multi-center clinical trial aims to explore and evaluate the efficacy and safety of arsenic trioxide combined with chemotherapy for pediatric cancer with p53 mutation.

NCT ID: NCT06055296 Not yet recruiting - Pediatric Cancer Clinical Trials

Multisite Implementation of COMPRENDO

COMPRENDO
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting implementation. This study will test the impact of COMPRENDO, a peer-navigation intervention, vs. usual care on accrual to childhood cancer therapeutic clinical trials and parental informed consent outcomes. COMPRENDO will be delivered by trained peer navigators in 4 visits. A mixed methods (surveys, individual interviews) implementation evaluation will examine implementation factors that can inform the use of peer navigation in clinical practice, integrating data from clinicians, navigators, administrators, and parents pre and post the RCT.

NCT ID: NCT06047808 Recruiting - Pediatric Cancer Clinical Trials

Feasibility Study of the Storytelling Through Music Intervention With Bereaved Parents

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The death of a child, at any age, is considered one of the most stressful life events a person can experience. In 2020, 11,050 children (under 15 years), 5,000 adolescents (15-19 years) and 60,000 young adults (20-39 years) were estimated to be diagnosed with cancer in the US. While the five-year survival is better for children than adults, over 10,000 children, adolescents, and young adults die from cancer in the US each year.1 Bereaved parents often experience intense and lasting psychological distress resulting in significantly higher morbidity and mortality compared to non-bereaved parents. Twenty-five percent of bereaved parents report new diagnoses of illnesses including prediabetes, anxiety and sleep disorders. Bereaved parents also experience psychological distress such as anxiety, post-traumatic stress disorder, and grief-related depressive symptoms that continue to be significant for years after a child's death. A recent study showed that nearly 33% of bereaved parents suffered from prolonged grief five years after their loss.6 Physiologically, studies show increased cortisol, immune, endocrine, and cardio biomarkers in people with prolonged grief. The death of a child can also affect family and social relationships resulting in decreased communication, feelings of isolation, absence of close social relationships and increased marital strain and divorce. The purpose of this randomized controlled pilot study is to evaluate the feasibility of implementing a six-week multi-dimensional intervention, Storytelling Through Music (STM), with parents of children who have died from cancer. STM combines multiple modalities of expression (storytelling, writing, and music) to facilitate loss- and restoration-oriented coping by creating a legacy piece (self-written story paired with song) to facilitate continuing bonds with the deceased and find meaning.

NCT ID: NCT06044142 Recruiting - Pediatric Cancer Clinical Trials

Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment

Start date: March 15, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this study is to assess the impact of non-invasive photodynamic therapy by Curcumin and photo-bio-modulation low level (LL) laser treatment in managing mucositis induced by chemotherapy in pediatric patients. A randomized clinical trial will be conducted involving 90 patients aged between 3 years and 15 years. The trial will be open, controlled, and blinded, and the patients will be divided into two groups.

NCT ID: NCT06033183 Not yet recruiting - Pediatric Cancer Clinical Trials

Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

FOCUSO
Start date: November 2, 2023
Phase: N/A
Study type: Interventional

Analysis of the individual radiosensitivity in pediatric oncology

NCT ID: NCT06023368 Enrolling by invitation - Pediatric Cancer Clinical Trials

Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray

Start date: December 23, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports. Participants will receive either the spray or cream prior to port access and rate pain on a scale. Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.

NCT ID: NCT06012825 Completed - Physical Activity Clinical Trials

Pediatric Physical Activity for Children With Cancer

PePA
Start date: January 1, 2022
Phase:
Study type: Observational

The goal of this pilot study is to test the feasibility and participant adherence (pediatric patients diagnosed with childhood cancer) to a virtual, 12-week physical activity program. The aims of this project are to: 1. Determine the feasibility of administering the program and patient acceptability. 2. Report program adherence and completion rates. 3. Explore trends on the impact of a virtual PA intervention on psychosocial health and physical fitness. Participants will undergo pre- and post-assessments including measurements of fitness, self-reported fatigue and depression symptoms, social support, and current amount of physical activity. Patients will then be invited to participate in two consecutive, 12-week virtual physical activity interventions with similar-aged peers (2x/week, 60 minutes/session) over 2 rounds.